96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

Authors:
Open Access
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • National Health and Medical Research Council (1176131, 1135991)
  • National Institute on Drug Abuse (R01DA1104470)
  • National Institutes of Health
  • National Drug and Alcohol Research Centre
  • Department of Health and Ageing, Australian Government
  • Indivior PLC

This publication has 35 references indexed in Scilit: